Gene Information
Gene Name
|
TDO2 |
Gene ID
|
6999
|
Gene Full Name
|
tryptophan 2,3-dioxygenase |
Gene Alias
|
TO; TDO; TPH2; TRPO; HYPTRP |
Transcripts
|
ENSG00000262635
|
Virus
|
HBV |
Gene Type
|
protein coding |
HPA Location Info
|
Cytosol;Plasma membrane;
|
HPA Protein Class Info
|
Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins |
Uniport_ID
|
P48775
|
HGNC ID
|
HGNC:11708
|
VEGA ID
|
OTTHUMG00000175318
|
OMIM ID
|
191070 |
String ID
|
9606.ENSP00000444788
|
Drugbank ID
|
BE0003532
|
PharmGKB ID
|
PA36427
|
Target gene [TDO2] related to VISs
DVID |
Chromosome |
HM |
TFBS |
CA |
Sum of Overlapped Records |
Detail |
1018302 |
chr4 |
|
|
|
0 |
View |
Relationship between gene expression and immune infiltrating cell level
Data ID |
Disease |
Sample number |
Sample type |
LIHC (TCGA) |
Liver hepatocellular carcinoma |
424 |
Liver hepatocellular carcinoma HCV (HBV+)(86), Liver hepatocellular carcinoma HCV (HBV-)(19), Liver hepatocellular carcinoma (HBV+)(209), Liver hepatocellular carcinoma (HBV+)(60), Paracancerous HCV (HBV+)(4), Paracancerous (HBV-)(28), Paracancerous (HBV+)(18) |
> Dataset: LIHC
|
HeatMap of cell type fractions in all samples
|
Lollipop of TDO2 expression and immune infiltrating cell level correlation result in HBV+ samples
|
TDO2 expression: Low -> High
|
|
|
|
|